Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

VTGNVTGN
13 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in VISTAGEN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 365,002 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $82,514 as of 2026-Q2. The position was decreased (-19.5% shares).

Current Value

$82,514

Current Shares

365,002

Total Value Change

-$24,678

Total Shares Change

+307,680

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
365,002
-19.5%
$82,5140.0%$0.23
0
2026-Q1
Increased
453,391
+28.5%
$259,1700.0%$0.61
20
2025-Q4
Increased
352,836
+18.3%
$233,6050.0%$0.68
18
2025-Q3
Increased
298,280
+9.3%
$1.1M0.0%$3.54
27
2025-Q2
Increased
272,907
+1.0%
$546,0020.0%$1.97
17
2025-Q1
Increased
270,187
+5.2%
$675,7530.0%$2.59
26
2024-Q4
Decreased
256,926
-0.6%
$758,2680.0%$2.81
0
2024-Q3
Decreased
258,524
-10.9%
$778,4330.0%$3.07
0
2024-Q2
Increased
290,094
+3.8%
$1M0.0%$3.48
26
2024-Q1
Increased
279,482
+1.8%
$1.5M0.0%$5.28
26
2023-Q4
Increased
274,472
+275.1%
$1.4M0.0%$5.14
41
2023-Q3
Increased
73,164
+27.6%
$383,5070.0%$5.24
20
2023-Q2
New
57,322
-
$107,1920.0%$1.80
33

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used